Nissha Co., Ltd.
Stock Price Chart
2026/10/09 12:26 UpdatedPrice Trend
2026/10/09 12:26 UpdatedPrice & Trading Details
2026/10/09 12:26 UpdatedPRICE
TRADING
Analyst Recommendations 4 analysts
Updated 2026/10/01Earnings Calendar
Updated 2026/10/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2026/05/11 | ¥51.40 | ¥8.92 | -82.7% |
| 2025/11/10 | ¥50.70 | ¥7.94 | -84.3% |
| 2025/05/08 | ¥40.60 | ¥1.84 | -95.5% |
| 2024/11/07 | ¥35.50 | ¥1.38 | -96.1% |
Shareholder Composition
Updated 2026/10/01Dividend History
Updated 2026/10/04| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥25 | -50.0% |
| 2025 | ¥50 | 0.0% |
| 2024 | ¥50 | 0.0% |
| 2023 | ¥50 | 0.0% |
| 2022 | ¥50 | - |
Financial Performance
2026/10/04 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥193,963M | ¥167,726M | ¥195,598M | ¥194,898M |
| Gross Profit | ¥42,422M | ¥32,622M | ¥43,798M | ¥43,695M |
| Operating Income | ¥9,578M | -¥3,574M | ¥5,789M | ¥4,400M |
| Pretax Income | ¥13,289M | -¥920M | ¥8,004M | ¥5,476M |
| Net Income | ¥10,140M | -¥2,988M | ¥3,851M | ¥1,001M |
| EPS | ¥203.65 | -¥61.13 | ¥79.93 | ¥21.13 |
| Operating Margin | 4.94% | -2.13% | 2.96% | 2.26% |
| Balance Sheet | ||||
| Total Assets | ¥230,212M | ¥217,853M | ¥251,847M | ¥250,120M |
| Total Equity | ¥111,553M | ¥110,913M | ¥114,297M | ¥115,316M |
| Total Liabilities | ¥118,659M | ¥106,940M | ¥137,550M | ¥134,804M |
| Cash | ¥54,325M | ¥37,854M | ¥50,970M | ¥39,213M |
| Interest-bearing Debt | ¥57,554M | ¥55,767M | ¥72,783M | ¥73,797M |
| Equity Ratio | 48.46% | 50.91% | 45.38% | 46.10% |
| D/E Ratio | 0.52 | 0.50 | 0.64 | 0.64 |
| Cash Flow | ||||
| Operating CF | ¥12,039M | ¥1,486M | ¥12,312M | ¥9,205M |
| Investing CF | -¥4,385M | -¥8,019M | -¥11,431M | -¥13,848M |
| Financing CF | ¥1,082M | -¥12,629M | ¥9,147M | -¥8,366M |
| Free CF | ¥5,974M | -¥3,991M | ¥4,155M | ¥1,358M |
| Efficiency | ||||
| ROE | 9.09% | -2.69% | 3.37% | 0.87% |
| ROA | 4.40% | -1.37% | 1.53% | 0.40% |
Latest IR Information
-
Notice Regarding Recognition of Impairment Loss (Consolidated) and Valuation Loss on Equity Securities of Affiliates (Non-consolidated)
Recognized goodwill impairment of 6,759 million yen and valuation loss on equity securities of affiliates of 6,133 million yen in the second quarter of the fiscal year ending December 2026. No additional impact on consolidated results; further disclosures planned regarding...
Read more -
Notice Regarding Differences from the Second Quarter (Interim) Consolidated Earnings Forecast and Revision of Full-Year Consolidated Earnings Forecast
Revised the full-year consolidated earnings forecast for the fiscal year ending December 2026. Net sales decreased by 3,000 million yen from the previous forecast; operating income, income before income taxes, and net income attributable to owners of parent were substantially...
Read more -
Financial Summary for the Second Quarter (Interim) of the Fiscal Year Ending December 2026
The second quarter (interim) financial summary for the fiscal year ending December 2026 reports net sales of 96,033 million yen, a 1.0% decrease year-over-year; operating loss of 4,500 million yen; and interim loss attributable to owners of parent of 5,473...
Read more -
Notice Regarding the Announcement Date for the Second Quarter (Interim) of the Fiscal Year Ending December 2026
The announcement date for the second quarter (interim) of the fiscal year ending December 2026 has been set for 2026-09-30. This is a follow-up to the notice published on August 4 regarding the postponement and consideration of an extension of...
Read more -
(Disclosure item progress) Notice regarding the completion of an amendment to the consolidated subsidiary (partial transfer of shares)
Partial transfer of holdings in USM HEALTHCARE MEDICAL DEVICES FACTORY JOINT STOCK COMPANY has been completed, and USM is excluded from the consolidated scope. The impact amount post-transfer is still undetermined, and its effect on the December-term consolidated earnings forecast...
Read more
Latest News (5 items)
-
Average Analyst Rating: hold
Average Target Price: ¥1,373
Rating Score: 3.00 (Based on 4 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Nissha Co., Ltd. engages in industrial materials, devices, medical technologies, information and communication, and pharmaceutical and cosmetics businesses in Japan and internationally. The company offers decorative film-molded parts, such as in-mold decoration technology and electronics, transfer foil, molding, CMF design sample book products, commercial printing; and sustainable materials, including metallized paper and board, and sustainable molded products. It is involved in the provision of touch, force, and gas sensors; the design and manufacture of medical technologies; development and manufacture of pharmaceuticals and quasi-drugs; design, development and manufacturing service of products such as surgical instruments for minimally invasive treatments and medical wearable sensors; and manufacturing and distributing patient monitoring and medical surgical devices. In addition, the company offers publication, high-definition digital archive photography, and fabric printing products and services; contract development and manufacturing film types of pharmaceuticals, such as oral thin films and transdermal patches; development and manufacturing of over-the-counter (OTC) and prescription drugs under contract manufacturing (CDMO); and dissolving microneedle patches; as well as produces and sells business media, including industrial recording materials and ticket/card materials. It serves mobility, mobile devices, home appliance, medical, food and consumer goods, cosmetics, and industrial equipment markets. The company was formerly known as Nissha Printing Co., Ltd. and changed its name to Nissha Co., Ltd. in 2017. Nissha Co., Ltd. was founded in 1929 and is headquartered in Kyoto, Japan.